2023
Representativeness of Peripheral Artery Disease Randomized Clinical Trials Supporting Current Guidelines
Castro-Dominguez Y, Mena-Hurtado C, Algara M, Obas V, Ahmed Z, Romain G, Solaru K, Smolderen K. Representativeness of Peripheral Artery Disease Randomized Clinical Trials Supporting Current Guidelines. The American Journal Of Cardiology 2023, 201: 166-169. PMID: 37385170, DOI: 10.1016/j.amjcard.2023.05.053.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiologyEthnicityFemaleHumansLower ExtremityPeripheral Arterial DiseaseRandomized Controlled Trials as TopicUnited StatesConceptsPeripheral artery diseasePAD guidelinesArtery diseaseRecent American Heart Association/American CollegeAmerican Heart Association/American CollegeLower extremity peripheral artery diseaseOlder adult patientsRace/ethnicity distributionAdult patientsPooled proportionMean ageClinical trialsCurrent guidelinesEpidemiologic studiesAmerican CollegeTrial participantsRCTsEthnicity distributionOlder adultsTrialsWomenPatientsDiseaseGuidelinesEthnic groups
2018
Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial
Pedersen SS, Skovbakke SJ, Wiil UK, Schmidt T, dePont Christensen R, Brandt CJ, Sørensen J, Vinther M, Larroudé CE, Melchior TM, Riahi S, Smolderen KGE, Spertus JA, Johansen JB, Nielsen JC. Effectiveness of a comprehensive interactive eHealth intervention on patient-reported and clinical outcomes in patients with an implantable cardioverter defibrillator [ACQUIRE-ICD trial]: study protocol of a national Danish randomised controlled trial. BMC Cardiovascular Disorders 2018, 18: 136. PMID: 29969990, PMCID: PMC6029360, DOI: 10.1186/s12872-018-0872-7.Peer-Reviewed Original ResearchMeSH KeywordsDefibrillators, ImplantableDenmarkElectric CountershockHealth StatusHeart FailureHumansMental HealthMulticenter Studies as TopicPatient Reported Outcome MeasuresPredictive Value of TestsProspective StudiesQuality of LifeRandomized Controlled Trials as TopicRemote Sensing TechnologyRisk FactorsTelemedicineTelemetryTime FactorsTreatment OutcomeConceptsImplantable cardioverter defibrillatorQuality of lifeEHealth interventionsUsual careClinical outcomesCardioverter defibrillatorFlorida Patient Acceptance SurveyCardiac synchronization therapyFirst ICD therapyTrial registrationThe trialCare innovationsManagement of patientsPatient-reported outcomesFirst‐time implantable cardioverter defibrillatorsMonitoring of symptomsQuality of carePatient-physician interactionFirst hospitalisationICD therapyPrimary endpointSecondary endpointsMore patientsSuperiority trialDisease management approachClinical effectiveness
2010
Letter by Smolderen and Pelle Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial”
Smolderen KG, Pelle AJ. Letter by Smolderen and Pelle Regarding Article, “Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial”. Circulation 2010, 122: e445; author reply e446. PMID: 20805437, DOI: 10.1161/circulationaha.110.942086.Peer-Reviewed Original ResearchMeSH KeywordsBenzazepinesCardiovascular DiseasesDepressionHumansNicotinic AgonistsPatient SelectionQuinoxalinesRandomized Controlled Trials as TopicRisk FactorsSmokingSmoking CessationVarenicline